Precipio Inc
Research Precipio Inc (PRPO) on Bullrun: market cap USD 55.19M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerPRPO
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyUSD
- Market capUSD 55.19M
- Financial periodQ1 2026
- RevenueUSD 6.71M
- Net income-USD 1.44M
- Free cash flowUSD 14.00K
- Gross margin40.6%
Valuation Snapshot
latest market cap is USD 55.19M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 24.25M | -USD 363.00K | USD 359.00K | 44.2% | -0.23 | USD 2.65M | USD 77.00K | USD 14.56M |
| FY2024 | USD 18.58M | -USD 4.29M | USD 216.00K | 40.7% | -2.93 | USD 1.39M | USD 374.00K | USD 12.09M |
| FY2023 | USD 15.42M | -USD 5.85M | -USD 3.69M | 39.0% | -4.51 | USD 1.50M | USD 341.00K | USD 14.43M |
| FY2022 | USD 9.82M | -USD 12.18M | -USD 8.00M | 25.6% | -10.73 | USD 3.45M | USD 389.00K | USD 16.30M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 55.19M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 40.93M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 8.27M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 9.23M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 12.57M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 35.88M | n/a | n/a | n/a |
About Precipio Inc
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers HemeScreen, a suite of robust genetic diagnostic panels; and IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Precipio Inc's market cap?
Precipio Inc's market capitalization is USD 55.19M.
What does Precipio Inc do?
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers HemeScreen, a suite of robust genetic diagnostic panels; and IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.